Skip to content

Clinical trials

Phase 3 Cardiotoxicity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Phase: Phase 3 Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20071
20092
20131
20151
20172
20181
20192
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Unknown status4
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group5
Ain Shams University1
Azienda Ospedaliero-Universitaria Careggi1
Cambridge University Hospitals NHS Foundation Trust1
Children's Cancer Hospital Egypt 573571
Fudan University1
Giulio Stefanini1
Maria Sklodowska-Curie National Research Institute of Oncology1
National Cancer Institute (NCI)1
SWOG Cancer Research Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity21
Breast Neoplasms7
Lymphoma4
Heart Failure3
Inflammatory Breast Neoplasms2
Lymphoma, Large B-Cell, Diffuse2
Bone Neoplasms1
Brain Neoplasms1
Breast Neoplasms, Male1
Dendritic Cell Sarcoma, Interdigitating1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.